126 related articles for article (PubMed ID: 36605009)
1. A case of refractory pelvic squamous cell carcinoma of unknown primary that responded to nivolumab.
Komura A; Taguchi A; Ikemura M; Nishijima A; Miyamoto Y; Tanikawa M; Sone K; Mori M; Oda K; Osuga Y
J Obstet Gynaecol Res; 2023 Apr; 49(4):1300-1304. PubMed ID: 36605009
[TBL] [Abstract][Full Text] [Related]
2. A matched comparison of human papillomavirus-induced squamous cancer of unknown primary with early oropharynx cancer.
Ross RB; Koyfman SA; Reddy CA; Houston N; Geiger JL; Woody NM; Joshi NP; Greskovich JF; Burkey BB; Scharpf J; Lamarre ED; Prendes B; Lorenz RR; Adelstein DJ; Ward MC
Laryngoscope; 2018 Jun; 128(6):1379-1385. PubMed ID: 29086413
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial.
Ferris RL; Spanos WC; Leidner R; Gonçalves A; Martens UM; Kyi C; Sharfman W; Chung CH; Devriese LA; Gauthier H; Chiosea SI; Vujanovic L; Taube JM; Stein JE; Li J; Li B; Chen T; Barrows A; Topalian SL
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34083421
[TBL] [Abstract][Full Text] [Related]
4. [Genomic Analysis-Based Treatment for Cancer of Unknown Primary].
Nishio K
Gan To Kagaku Ryoho; 2022 Mar; 49(3):259-263. PubMed ID: 35299177
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment using immunotherapy in combination with chemotherapy for metastatic squamous cell carcinoma of unknown primary origin with bulky abdominal mass: A case report.
Zhang M; Zhao M; Jin LF; Shen WZ
Medicine (Baltimore); 2021 Dec; 100(48):e28074. PubMed ID: 35049231
[TBL] [Abstract][Full Text] [Related]
6. Immunochemotherapy achieved a complete response for metastatic adenocarcinoma of unknown primary based on gene expression profiling: a case report and review of the literature.
Sheng J; Pan H; Han W
Front Immunol; 2023; 14():1181444. PubMed ID: 37153561
[TBL] [Abstract][Full Text] [Related]
7. Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response.
Baettig F; Vlajnic T; Vetter M; Glatz K; Hench J; Frank S; Bihl M; Lopez R; Dobbie M; Heinzelmann-Schwarz V; Montavon C
J Immunother Cancer; 2019 Oct; 7(1):281. PubMed ID: 31672171
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive management of HPV-related squamous cell carcinoma of the head and neck of unknown primary.
Rassy E; Nicolai P; Pavlidis N
Head Neck; 2019 Oct; 41(10):3700-3711. PubMed ID: 31301162
[TBL] [Abstract][Full Text] [Related]
9. Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study.
Chen AM; Felix C; Wang PC; Hsu S; Basehart V; Garst J; Beron P; Wong D; Rosove MH; Rao S; Melanson H; Kim E; Palmer D; Qi L; Kelly K; Steinberg ML; Kupelian PA; Daly ME
Lancet Oncol; 2017 Jun; 18(6):803-811. PubMed ID: 28434660
[TBL] [Abstract][Full Text] [Related]
10. Unusual presentation of HPV-positive squamous cell carcinoma of the nasolacrimal duct as carcinoma of unknown primary.
Mokhtari TE; Warinner C; Edwards H; Chan AW; Annino D; Schoenfeld JD; Sethi RKV; Rettig EM
Am J Otolaryngol; 2022; 43(3):103457. PubMed ID: 35453094
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
[TBL] [Abstract][Full Text] [Related]
12. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel/carboplatin plus bevacizumab/erlotinib in the first-line treatment of patients with carcinoma of unknown primary site.
Hainsworth JD; Spigel DR; Thompson DS; Murphy PB; Lane CM; Waterhouse DM; Naot Y; Greco FA
Oncologist; 2009 Dec; 14(12):1189-97. PubMed ID: 19965914
[TBL] [Abstract][Full Text] [Related]
14. Site of analysis matters - Ongoing complete response to Nivolumab in a patient with HIV/HPV related metastatic anal cancer and
Demes M; Pession U; Jeroch J; Schulze F; Eichler K; Martin D; Wild P; Waidmann O
Oncotarget; 2022; 13():1034-1042. PubMed ID: 36128324
[TBL] [Abstract][Full Text] [Related]
15. p16 status, pathologic and clinical characteristics, biomolecular signature, and long-term outcomes in head and neck squamous cell carcinomas of unknown primary.
Keller LM; Galloway TJ; Holdbrook T; Ruth K; Yang D; Dubyk C; Flieder D; Lango MN; Mehra R; Burtness B; Ridge JA
Head Neck; 2014 Dec; 36(12):1677-84. PubMed ID: 24115269
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel/carboplatin with or without belinostat as empiric first-line treatment for patients with carcinoma of unknown primary site: A randomized, phase 2 trial.
Hainsworth JD; Daugaard G; Lesimple T; Hübner G; Greco FA; Stahl MJ; Büschenfelde CM; Allouache D; Penel N; Knoblauch P; Fizazi KS
Cancer; 2015 May; 121(10):1654-61. PubMed ID: 25611313
[TBL] [Abstract][Full Text] [Related]
17. A patient with advanced lung squamous cell carcinoma who failed to benefit from albumin bound paclitaxel plus pembrolizumab achieved partial response with second-line treatment of docetaxel plus pembrolizumab: a case report.
Zhang F; Xu Y; Guo S; Li S; Ma K; Wang J; Wei S
Ann Palliat Med; 2022 Sep; 11(9):3020-3027. PubMed ID: 36217630
[TBL] [Abstract][Full Text] [Related]
18. Association of Extracapsular Spread With Survival According to Human Papillomavirus Status in Oropharynx Squamous Cell Carcinoma and Carcinoma of Unknown Primary Site.
Kharytaniuk N; Molony P; Boyle S; O'Leary G; Werner R; Heffron C; Feeley L; Sheahan P
JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):683-690. PubMed ID: 27196434
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus in metastatic squamous carcinoma from unknown primaries in the head and neck: a retrospective 7 year study.
Desai PC; Jaglal MV; Gopal P; Ghim SJ; Miller DM; Farghaly H; Jenson AB
Exp Mol Pathol; 2009 Oct; 87(2):94-8. PubMed ID: 19393644
[TBL] [Abstract][Full Text] [Related]
20. Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site.
Hayashi H; Kurata T; Takiguchi Y; Arai M; Takeda K; Akiyoshi K; Matsumoto K; Onoe T; Mukai H; Matsubara N; Minami H; Toyoda M; Onozawa Y; Ono A; Fujita Y; Sakai K; Koh Y; Takeuchi A; Ohashi Y; Nishio K; Nakagawa K
J Clin Oncol; 2019 Mar; 37(7):570-579. PubMed ID: 30653423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
